Molecule Details

Natural Product(s) of This Target
1 Dopamine  NP Info  Approved Lactiplantibacillus plantarum
2 Levodopa  NP Info  Approved Mucuna pruriens
3 Olanzapine  NP Info  Approved Homo sapiens
4 Pseudoephedrine  NP Info  Approved Ephedra altissima
Drug(s) of This Target
1 Domperidone  Drug Info  Approved Digestive system disease
2 Phentolamine  Drug Info  Approved Gangrene
3 Phenylephrine  Drug Info  Approved Thyrotoxicosis
4 Thioridazine  Drug Info  Approved Schizophrenia
References
Reference 1 The Detection of Dopamine Gene Receptors (DRD1-DRD5) Expression on Human Peripheral Blood Lymphocytes by Real Time PCR. Iran J Allergy Asthma Immunol. 2004 Dec;3(4):169-74.
Reference 2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3639).
Reference 3 Olanzapine: an updated review of its use in the management of schizophrenia. Drugs. 2001;61(1):111-61.
Reference 4 Cetirizine/pseudoephedrine. Drugs. 2001;61(15):2231-40; discussion 2241-2.
Reference 5 Screening of domperidone in wastewater by high performance liquid chromatography and solid phase extraction methods. Talanta. 2006 Jan 15;68(3):928-31.
Reference 6 Nesfatin-1 exerts cardiovascular actions in brain: possible interaction with the central melanocortin system. Am J Physiol Regul Integr Comp Physiol. 2009 Aug;297(2):R330-6.
Reference 7 MMP-2 induced vein relaxation via inhibition of [Ca2+]e-dependent mechanisms of venous smooth muscle contraction. Role of RGD peptides. J Surg Res. 2010 Apr;159(2):755-64.
Reference 8 Antipsychotics lack alpha 1A/B adrenoceptor subtype selectivity in the rat. Eur Neuropsychopharmacol. 2005 Mar;15(2):231-4.